Protease inhibitors
K |
|||
| Zeile 1: | Zeile 1: | ||
| + | {{up|PHA antivirals by mechanism}} | ||
'''host proteases''' | '''host proteases''' | ||
Aktuelle Version vom 18. Januar 2021, 20:09 Uhr
| PHA antivirals by mechanism |
host proteases
32577236 2020. Preventing SARS-CoV-2 infection by blocking a tissue serine protease.
32537610 2020. Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19.
cathepsin L
32470470 2020. Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients.
Camostat mesilate serine proteinase inh
32347443 ä. Camostat mesilate therapy for COVID-19
32489508 2020. Simultaneous Treatment of COVID-19 With Serine Protease Inhibitor Camostat and/or Cathepsin L Inhibitor?
Nafamostat mesilate serine proteinase inh
32312781 2020. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
32302456 2020. Potential of heparin and nafamostat combination therapy for COVID-19
32470602 2020. Three cases of treatment with Nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy.
| 32532094 2020. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. |
